Astragalus
Background
Astragalus
has been used for centuries in traditional Chinese medicine in
combination with other herbs, such as ginseng, dong quai,
and licorice.
There are more than 2,000 species of astragalus.
Astragalus
has been used as a dietary supplement for many conditions, including
for diarrhea, fatigue, anorexia, upper respiratory infections, heart
disease, hepatitis, fibromyalgia, and as an adjunctive therapy
for cancer.
The root of the astragalus plant is put in soups, teas, extracts,
or capsules.
How Much Do We Know?
There are no high-quality studies in people of astragalus for any
health conditions.
What Have We Learned?
Patients
with nephrotic syndrome (health problems related to kidney damage) are
susceptible to infections. A 2012 research review found that taking
astragalus granules may be associated with a lower risk of infections
in children with nephrotic syndrome. However, the review concluded that
the studies were poor quality.
People with diabetic nephropathy
(a type of kidney disease) who received an intravenous drip of
astragalus over a period of 2 to 6 weeks did better on some measures of
kidney function, compared to people who didn’t get astragalus,
according to a 2011 analysis of 25 studies. However, most of the trials
involved were poor quality.
There’s weak evidence that
astragalus may help heart function in some patients with viral
myocarditis (an infection of the heart), a 2013 research
review showed.
Because of limitations in the studies, a 2013
research review on the effects of astragalus on fatty liver disease,
which causes fat to build up in liver cells, couldn’t determine whether
astragalus helps.
An astragalus-based herbal formula didn’t
extend the life of patients with advanced lung cancer, a small 2009
trial reported. The study was supported in part by the National Center
for Complementary and Integrative Health (NCCIH).
What Do We Know About Safety?
Astragalus
is considered safe for many adults. The most commonly reported side
effects are diarrhea and other mild gastrointestinal effects. However,
it may affect blood sugar levels and blood pressure and be risky for
people with certain health problems, such as blood disorders, diabetes,
or hypertension.
Astragalus may interact with medications that
suppress the immune system, such as drugs taken by organ transplant
recipients and some cancer patients.
Some astragalus species,
usually not found in dietary supplements, can be toxic. Several species
that grow in the United States contain the neurotoxin swainsonine and
have caused “locoweed” poisoning in animals. Other species contain
potentially toxic levels of selenium.
Key References
- Astragalus.
Natural Medicines Web site. Accessed at
naturalmedicines.therapeuticresearch.com on March 19, 2015.
[Database subscription].
- Cassileth
BR, Rizvi N, Deng G, et al. Safety
and pharmacokinetic trial of docetaxel plus an astragalus-based herbal
formula for non-small cell lung cancer patients. Cancer Chemotherapy and
Pharmacology. 2009;65(1):67-71.
- Guo
L, Bai SP, Zhao L, et al. Astragalus
polysaccharide injection integrated with vinorelbine and cisplatin for
patients with advanced non-small cell lung cancer: effects on quality
of life and survival. Medical Oncology. 2012;29(3):1656-1662.
- Li
M, Wang W, Xue J, et al. Meta-analysis
of the clinical value of Astragalus membranaceus in
diabetic nephropathy. Journal of Ethnopharmacology. 2011;133(2):412-419.
- Liu
ZL, Liu ZJ, Liu JP, et al. Herbal medicines for viral myocarditis. Cochrane Database of Systematic
Reviews. 2013;(11):
CD003711. Accessed at http://www.thecochranelibrary.com(link
is external) on
March 31, 2015.
- Liu
ZL, Xie LZ, Zhu J, et al. Herbal medicines for fatty liver diseases. Cochrane Database of Systematic
Reviews 2013;(
8):CD009059. Accessed at http://www.thecochranelibrary.com(link
is external) on
March 31, 2015.
- Upton
R. Astragalus. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of Dietary
Supplements. 2nd
ed. New York, NY: Informa Healthcare; 2010:29-36.
- Wu
HM, Tang JL, Cao L, et al. Interventions for preventing infection in
nephrotic syndrome. Cochrane Database of Systematic
Reviews. 2012;(4):CD003964.
Accessed at http://www.thecochranelibrary.com(link
is external) on
March 31, 2015.
-NIH